Barclays
TRPX

Barclays’s Therapix Biosciences Ltd. TRPX Stock Holding History

Barclays’s Portfolio TRPX Stock Details TRPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-681
Closed -$2K – 7514
2018
Q4 		$2K Buy
+681
New +$3.95K ﹤0.01% 6763

Other funds holding TRPX

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

Barclays's TRPX Position: Q1 2019 in Review

Barclays sold out of Therapix Biosciences Ltd. (TRPX) in Q1 2019, closing a stake of 681 shares — an estimated $2K sold.

Barclays first reported a position in TRPX in Q4 2018 and held it in 1 quarter. The position peaked at $2K in Q4 2018. 4 funds tracked by Wall St. Rank hold TRPX as of Q1 2019.

  • Barclays reported no remaining Therapix Biosciences Ltd. position as of Q1 2019 after selling out during the quarter.
  • Barclays sold 681 Therapix Biosciences Ltd. shares in Q1 2019, an estimated $2K.
  • Barclays first reported a position in Therapix Biosciences Ltd. in Q4 2018 and held it in 1 quarter.
  • Barclays's Therapix Biosciences Ltd. position peaked at $2K in Q4 2018.
  • 4 funds tracked by Wall St. Rank held Therapix Biosciences Ltd. as of Q1 2019.

Based on Barclays's 13F filing for Q1 2019, filed 15 May 2019.